Clinicopathologic study of mass-screened neuroblastoma with special emphasis on untreated observed cases: A possible histologic clue to tumor regression

American Journal of Surgical Pathology

Volumn 24, Issue 6, 2000, Pages 807-815

  Ijiri, Rieko ^b   Tanaka, Yukichi ^c   Kato, Keisuke ^c   Misugi, Kazuaki ^c   Nishihira, Hirokazu ^c   Toyoda, Yasunori ^c   Kigasawa, Hisato ^c   Nishi, Toshiji ^c   Takeuchi, Maho ^c   Aida, Noriko ^c   Momoi, Takashi ^a  

^a NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

^b Medical Center   (Japan)

^c NONE

Author keywords

Activated caspase 3; Amorphic cells; Mass screening; Neuroblastoma; Plump cells; TUNEL; Untreated observation

Indexed keywords

CASPASE 3;

APOPTOSIS; ARTICLE; CANCER REGRESSION; CANCER SURGERY; CHILDHOOD CANCER; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFANT; MASS SCREENING; NEUROBLASTOMA; PRESCHOOL CHILD;

AGE FACTORS; APOPTOSIS; CHILD; CHILD, PRESCHOOL; DATA INTERPRETATION, STATISTICAL; GANGLIONEUROBLASTOMA; GANGLIONEUROMA; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; MASS SCREENING; NEOPLASM REGRESSION, SPONTANEOUS; NEUROBLASTOMA; PROGNOSIS; RISK FACTORS;

EID: 0034130191     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000478-200006000-00005     Document Type: Article

References (33)

1. Bessho F, Hashizume K, Nakajo T, Kamoshita S. Mass screening in Japan increased the detection of infants with neuroblastoma without a decrease in cases in older children. J Pediatr 1991;119: 237-41.
2. Brodeur GM, Seeger RC, Barrett A. International criteria for diagnosis, staging and response to treatment in patients with neuroblastoma. J Clin Oncol 1988;6:1874-81.
3. Brodeur GM, Seeger RC, Schwab M, Varmus HE, Bishop JM. Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science 1984;224:1121-4.
4. Chatten J, Shimada H, Sather HN, Wong KY, Siegel SE, Hammond GD. Prognostic value of histopathology in advanced neuroblastoma: a report from the Childrens Cancer Study Group. Hum Pathol 1988;19:1187-98.
5. Chi S, Kitanaka C, Noguchi K, et al. Oncogenic Ras triggers cell suicide through the activation of a caspase-independent cell death program in human cancer cells. Oncogene 1999;18:2281-90.
6. Clarke PGH. Developmental cell death: morphological diversity and multiple mechanisms. Anat Embryol 1990;181:195-213.
7. Faherty CJ, Xanthoudakis S, Smeyne RJ. Caspase-3-dependent neuronal death in the hippocampus following kainic acid treatment. Mol Brain Res 1999;70:159-63.
8. Fukasaka Y, Ishikawa H, Takeda A, et al. Massive apoptosis in infantile myofibromatosis. A putative mechanism of tumor regression. Am J Pathol 1994;144:480-5.
9. Hiraiwa H, Hamazaki M, Takata, Kikuchi H, Hata J. A neuroblastoma cell line derived from a case detected through a mass screening system in Japan. Cancer 1997;79:2036-44.
10. Hoehner JC, Hedborg F, Wiklund HJ, Olsen L, Phalman S. Cellular death in neuroblastoma: in situ correlation of apoptosis and bcl-2 expression. Int J Cancer 1995;62:19-24.
11. Ijiri R, Tanaka Y, Misugi K, Kato K, Nishihira H, Nishi T. Observed cases of mass-screening positive neuroblastoma [Abstract]. Med Pediatr Oncol 1998;31:301.
12. Ikeda H, Hirato J, Akami M, et al. Massive apoptosis detected by in situ DNA nick end labeling in neuroblastoma. Am J Surg Pathol 1996;20:649-55.
13. Joshi VV, Cantor AB, Altshuler G, et al. Recommendation for modification of terminology of neuroblastic tumors and prognostic significance of Shimada classification. A clinicopathologic study of 213 cases from the Pediatric Oncology Group. Cancer 1992; 69:2183-96.
14. Kaneko Y, Kanda N, Maseki N, et al. Different karyotypic patterns in early and advanced stage neuroblastomas. Cancer Res 1987;47: 311-8.
15. Kitanaka C, Kuchino Y. Caspase-independent programmed cell death with necrotic morphology. Cell Death Differ 1999;6:508-15.
16. Kouroku Y, Urase K, Fujita E, et al. Detection of activated caspase-3 by a cleavage site-directed antiserum during naturally occurring DRG neurons apoptosis. Biochem Biophys Res Commun 1998;247:780-4.
17. Kulkarni AV, Bilbao JM, Cusimano MD, Juller PJ. Malignant transformation of ganglioneuroma into spinal neuroblastoma in an adult. J Neurosurg 1998;88:324-7.
18. Look AT, Hayes FA, Shuster JJ, et al. Clinical relevance of tumor cell ploidy and N-myc gene amplification in childhood neuroblastoma: a Pediatric Oncology Group study. J Clin Oncol 1991;9: 581-91.
19. Matsumura M, Tsunoda A, Nishi T. Spontaneous regression of neuroblastoma detected by mass screening [Letter]. Lancet 1990; 338:447-8.
20. Miho Y, Kouroku Y, Fujita E, et al. BFGF inhibits the activation of caspase-3 and apoptosis of P19 embryonal carcinoma cells during neuronal differentiation. Cell Death Differ 1999;6:463-70.
21. Mir R, Phillips SL, Schwartz G, Mathur R, Khan A, Kahn LB. Metastatic neuroblastoma after 52 years of dormancy. Cancer 1987;60:2510-4.
22. Nishihira H, Tanaka Y, Ijiri R. Untreated observation of infantile neuroblastoma (in Japanese). Pathology and Clinical Medicine 1999;17:435-40.
23. Nishihira H, Toyoda Y, Tanaka Y, et al. A prospective study for spontaneous regression and maturation of neuroblastoma detected by mass-screening program. Med Pediatr Oncol 1998;31:260-1.
24. Peto R, Pike MC, Armitage P. Design and analysis of randomized clinical trials: part II. Analysis & examples. Br J Cancer 1997;35: 1-39.
25. Shimada H, Chatten J, Newton WA. Histopathologic prognostic factors in neuroblastic tumors: definition of subtypes of ganglio-neuroblastoma and an age-linked classification of neuroblastomas. J Natl Cancer Inst 1984;73:405-16.
26. Shimada H, Ambros I, Dehner LP, Hata J, Joshi VV, Roald B. Terminology and morphologic criteria of neuroblastic tumors: recommendations by the International Neuroblastoma Pathology Committee. Cancer 1999;86:349-63.
27. Susin SA, Zamzami N, Castedo M, et al. The central executioner of apoptosis: multiple connections between protease activation and mitochondria in Fas/APO-1/CD95 and ceramide-induced apoptosis. J Exp Med 1997;186:25-37.
28. Thornberry NA, Lazebnik Y. Caspases: enemies within. Science 1998;281:1312-6.
29. Urase K, Momoi T, Fujita E, et al. Bcl-xL is a negative regulator of caspase-3 activation in immature neurons during development. Dev Brain Res 1999;116:69-78.
30. Woods WG, Tuchman M, Robison LL, et al. Screening for neuroblastoma is ineffective in reducing the incidence of unfavourable advanced stage disease in older children. Eur J Cancer 1997;33: 2106-112.
31. Xiang J, Chao DT, Korsmeyer SJ. Bax-induced cell death may not require interleukin 1 beta-converting enzyme-like proteases. Proc Natl Acad Sci U S A 1996;93:14559-63.
32. Yamamoto K, Hanada R, Kikuchi A, et al. Spontaneous regression of localized neuroblastoma detected by mass screening. J Clin Oncol 1998;16:1265-9.
33. Yamamoto K, Hanada R, Tanimura M, Aihara T, Hayashi Y. Natural history of neuroblastoma found by mass screening. Lancet 1997;349:1102. Letter.